Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study

Acute exacerbations of chronic obstructive pulmonary disease (COPD) with severe hyperglycemia may require insulin to lower glucose levels in people with coexisting type 2 diabetes (T2D) and COPD. We conducted this study to examine the risk of hospitalization for COPD, pneumonia, ventilator use, lung...

Full description

Bibliographic Details
Main Authors: Fu-Shun Yen, Shu-Hao Chang, James Cheng-Chung Wei, Ying-Hsiu Shih, Chii-Min Hwu
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/5/643
_version_ 1797598746867924992
author Fu-Shun Yen
Shu-Hao Chang
James Cheng-Chung Wei
Ying-Hsiu Shih
Chii-Min Hwu
author_facet Fu-Shun Yen
Shu-Hao Chang
James Cheng-Chung Wei
Ying-Hsiu Shih
Chii-Min Hwu
author_sort Fu-Shun Yen
collection DOAJ
description Acute exacerbations of chronic obstructive pulmonary disease (COPD) with severe hyperglycemia may require insulin to lower glucose levels in people with coexisting type 2 diabetes (T2D) and COPD. We conducted this study to examine the risk of hospitalization for COPD, pneumonia, ventilator use, lung cancer, hypoglycemia, and mortality with and without insulin use in people with T2D and COPD. We adopted propensity-score-matching to identify 2370 paired insulin users and non-users from Taiwan’s National Health Insurance Research Database between 1 January 2000 and 31 December 2018. Cox proportional hazards models and the Kaplan–Meier method were utilized to compare the risk of outcomes between study and control groups. The mean follow-up for insulin users and non-users was 6.65 and 6.37 years. Compared with no insulin use, insulin use was associated with a significantly increased risk of hospitalization for COPD (aHR 1.7), bacterial pneumonia (aHR 2.42), non-invasive positive pressure ventilation (aHR 5.05), invasive mechanical ventilation (aHR 2.72), and severe hypoglycemia (aHR 4.71), but with no significant difference in the risk of death. This nationwide cohort study showed that patients with T2D and COPD requiring insulin therapy may have an increased risk of acute COPD exacerbations, pneumonia, ventilator use, and severe hypoglycemia without a significant increase in the risk of death.
first_indexed 2024-03-11T03:25:01Z
format Article
id doaj.art-0cd02700e1d44508997233bfff38195b
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-11T03:25:01Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-0cd02700e1d44508997233bfff38195b2023-11-18T02:47:54ZengMDPI AGPharmaceuticals1424-82472023-04-0116564310.3390/ph16050643Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort StudyFu-Shun Yen0Shu-Hao Chang1James Cheng-Chung Wei2Ying-Hsiu Shih3Chii-Min Hwu4Dr. Yen’s Clinic, No. 15, Shanying Road, Gueishan District, Taoyuan 33354, TaiwanDivision of Pulmonary Medicine, Department of Internal Medicine, Cheng Ching Hospital, No. 139, Pingdeng Street, Central District, Taichung 40045, TaiwanDepartment of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo N. Road, South District, Taichung 40201, TaiwanManagement Office for Health Data, China Medical University Hospital, Taichung 40201, TaiwanFaculty of Medicine, National Yang-Ming Chiao Tung University School of Medicine, No. 155, Section 2, Linong Street, Taipei 11221, TaiwanAcute exacerbations of chronic obstructive pulmonary disease (COPD) with severe hyperglycemia may require insulin to lower glucose levels in people with coexisting type 2 diabetes (T2D) and COPD. We conducted this study to examine the risk of hospitalization for COPD, pneumonia, ventilator use, lung cancer, hypoglycemia, and mortality with and without insulin use in people with T2D and COPD. We adopted propensity-score-matching to identify 2370 paired insulin users and non-users from Taiwan’s National Health Insurance Research Database between 1 January 2000 and 31 December 2018. Cox proportional hazards models and the Kaplan–Meier method were utilized to compare the risk of outcomes between study and control groups. The mean follow-up for insulin users and non-users was 6.65 and 6.37 years. Compared with no insulin use, insulin use was associated with a significantly increased risk of hospitalization for COPD (aHR 1.7), bacterial pneumonia (aHR 2.42), non-invasive positive pressure ventilation (aHR 5.05), invasive mechanical ventilation (aHR 2.72), and severe hypoglycemia (aHR 4.71), but with no significant difference in the risk of death. This nationwide cohort study showed that patients with T2D and COPD requiring insulin therapy may have an increased risk of acute COPD exacerbations, pneumonia, ventilator use, and severe hypoglycemia without a significant increase in the risk of death.https://www.mdpi.com/1424-8247/16/5/643mortalitybacterial pneumonianon-invasive positive pressure ventilationinvasive mechanical ventilationhypoglycemia
spellingShingle Fu-Shun Yen
Shu-Hao Chang
James Cheng-Chung Wei
Ying-Hsiu Shih
Chii-Min Hwu
Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
Pharmaceuticals
mortality
bacterial pneumonia
non-invasive positive pressure ventilation
invasive mechanical ventilation
hypoglycemia
title Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
title_full Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
title_fullStr Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
title_full_unstemmed Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
title_short Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
title_sort respiratory outcomes of insulin use in patients with copd a nationwide population based cohort study
topic mortality
bacterial pneumonia
non-invasive positive pressure ventilation
invasive mechanical ventilation
hypoglycemia
url https://www.mdpi.com/1424-8247/16/5/643
work_keys_str_mv AT fushunyen respiratoryoutcomesofinsulinuseinpatientswithcopdanationwidepopulationbasedcohortstudy
AT shuhaochang respiratoryoutcomesofinsulinuseinpatientswithcopdanationwidepopulationbasedcohortstudy
AT jameschengchungwei respiratoryoutcomesofinsulinuseinpatientswithcopdanationwidepopulationbasedcohortstudy
AT yinghsiushih respiratoryoutcomesofinsulinuseinpatientswithcopdanationwidepopulationbasedcohortstudy
AT chiiminhwu respiratoryoutcomesofinsulinuseinpatientswithcopdanationwidepopulationbasedcohortstudy